Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS-Reference-Cited by-同舟云学术

Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS

Published:2012-11-14 Issue:4 Volume:60 Page:705-710
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Smith Angela R.,Christiansen Ellen C.,Wagner John E.,Cao Qing,MacMillan Margaret L.,Stefanski Heather E.,Trotz Barbara A.,Burke Michael J.,Verneris Michael R.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24390/fullpdf

Reference43 articles.

1. Myelodysplastic syndrome in children and adolescents;Niemeyer;Semin Hematol,2008

2. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases;Hasle;Leukemia,2003

3. Myelodysplastic and myeloproliferative disorders in children;Hasle;Curr Opin Pediatr,2007

4. Myelodysplastic syndromes: The pediatric point of view;Locatelli;Haematologica,1995

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial;Pediatric Blood & Cancer;2024-03-03

2. Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation;Clinical Case Reports;2023-11

3. A Rare Concurrence of Myelodysplastic Neoplasia and Tetrasomy 8 in a 3-Year-Old Bahraini Male;Cureus;2023-07-17

4. Disease burden at time of transplant is a primary predictor of outcomes in pediatric MDS: A single center experience;2023-07-13

5. Impact of cytoreduction and remission status on hematopoietic cell transplantation outcomes in pediatric myelodysplastic syndrome and related disorders;Pediatric Blood & Cancer;2023-06-27